Acutaas Chemicals Ltd · NSE:ACUTAAS
Acutaas Chemicals — Q2 FY27 Earnings Presentation
12 slides from Acutaas Chemicals's earnings presentation, Oct 27, 2026
Slide 1: You and us: chemistry's apex
A fi C U T fi a S® ACUTAAS CHEMICALS LIMITED (Formerly known as Ami Organics Limited) CIN No. : L24100GJ2007PLCO51093 You and us: chemistry’s apex October 27, 2026 To, To, The Listing Department, The Listing Department BSE LIMITED, National Stock Exchange of India Limited, Phiroze Jeejeebhoy Towers, E
Slide 2: Earnings Presentation October 2026
EARNINGS PRESENTATION OCTOBER 2026 www.acutaas.com www.acutaas.com
Slide 3: Management Commentary
Management Commentary (Mn.) Revenue for Q2 FY27 Mr. Naresh Patel Executive Chairman and Managing Director “We delivered strong revenue of ₹4,369 million, representing ₹4,369 42.7% year-on-year growth. The performance was led by the YoY ▲ continued momentum in our Pharmaceutical Intermediates 42.7% b
Slide 4: Q2 FY27 Financial Performance – Key Metrics
Q2 FY27 Financial Performance – Key Metrics Revenue from Operations (₹ Mn.) Q2 FY27 Earnings & Business Highlights YoY Growth 53.1% (20.0%) 42.7% Pharma Intermediates 4,369 4,020 CDMO as well as Core Advanced intermediate 3,062 business delivered robust growth 2,626 Specialty Chemicals 436 349 Decli
Slide 5: H1 FY27 Financial Performance – Key Metrics
H1 FY27 Financial Performance – Key Metrics Revenue from Operations (₹ Mn.) YoY Growth 62.2% (15.6%) 49.3% 7,665 6,947 5,134 4,284 850 718 Advance Intermediates Specialty Chemicals Total H1FY26 H1FY27 EBITDA & EBITDA Margin (₹ Mn) PAT (₹ Mn.) 37.7% 25.8% 28.5% 22.6% 1,462 2,890 1,159 1,981 H1FY26 H1
Slide 6: Q2 & H1 FY27 Financial Performance – P&L Statement
Q2 & H1 FY27 Financial Performance – P&L Statement Particulars (Rs. Mn) Q2FY27 Q2FY26 YoY Q1FY27 QoQ H1FY27 H1FY26 YoY Revenue from Operations 4,369 3,062 42.7% 3,297 32.5% 7,666 5,134 49.3% COGS 1,654 1,355 1,388 3,042 2,323 Gross Profit 2,715 1,707 59.0% 1,909 42.2% 4,624 2,811 64.5% Gross Margin
Slide 7: Financial Performance over the years – Key Metrics
Financial Performance over the years – Key Metrics Revenue from Operations- Growth Trends (₹ Mn.) EBITDA and EBITDA Margins (₹ Mn. & %) FY21-26 CAGR: EBITDA (₹ Mn) EBITDA Margin (%) 29.4% 58.3% 31.5% 37.7% 35.9% FY21 FY22 FY23 FY24 FY25 FY26 H1 FY27 13,394 11,741 23.0% 8,540 23.5% 7,175 20.2% 19.9%
Slide 8: Financial Performance over the years - Profit and Loss
Financial Performance over the years - Profit and Loss H1 Particulars (₹ Mn.) FY21 FY22 FY23 FY24 FY25 FY26 FY27 Revenue from Operations 3,406 5,201 6,167 7,175 10,069 13,394 7,666 Other Income 14 28 43 75 169 416 69 Total Income 3,420 5,229 6,210 7,250 10,238 13,810 7,735 Cost of materials consumed
Slide 9: Financial Performance over the years - Balance Sheet
Financial Performance over the years - Balance Sheet H1 Liabilities & Equity (₹ H1 Assets (₹ Mn.) FY21 FY22 FY23 FY24 FY25 FY26 FY21 FY22 FY23 FY24 FY25 FY26 FY27 Mn.) FY27 Property, plant and equipment 1,422 1,584 1,844 3,229 4,629 5,828 9,545 Shareholder's equity 1,669 5,223 5,939 6,828 13,201 17,
Slide 10: Shareholder Information
Shareholder Information Shareholding as on 30th September 2026 Share Information as on 30th September 2026 Others Promoters NSE Ticker ACUTAAS 25.3% 32.7% BSE Ticker 543349 Market Cap (₹ Cr.) 29,208 Shares Outstanding 8,18,71,122 3M ADTV (Shares) 3,47,404 3M ADTV (₹ Cr.) 115.7 MF FII 22.6% 14.4% Ind
Slide 11: Safe Harbor
Safe Harbor The Presentation is to provide the general background information about the Company’s activities as at the date of the Presentation. The information contained herein is for general information purposes only and based on estimates and should not be considered as a recommendation that any
Slide 12: Contact Us
Contact Us For more information please contact: Acutaas Chemicals Limited Ekta Srivastava Company Secretary & Compliance Officer [email protected] Rahul Thakur Senior Manager – Investor Relations [email protected] www.acutaas.com www.acutaas.com Disclaimer: This presentation contains forward-loo